Insulin Gla-100 and detemir have a significantly lower rate of hypoglycemia compared to NPH while the second-generation long-acting basal insulin preparations, degludec and the Gla-300, are superior in terms of pharmacokinetic and pharmacodynamic properties as compared to the currently available first-generation basal insulin preparations [28]. Here, INS is linked to Hypoglycemia.